The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects

NCT03811678 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis c

Interventions

DRUG: Kangdaprevir Sodium Tablet
DRUG: placebo

Sponsor

Sunshine Lake Pharma Co., Ltd.